Expression of Insulin-Like Growth Factor-II and Its Receptor in Pediatric and Adult Adrenocortical Tumors

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860

Changing patterns in the incidence of esophageal and gastric carcinoma in the United States

Devesa, S. S., Blot, W. J., & Fraumeni, J. F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981115)83:10 · Cited by 2,097

The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights

Samani, A. A., Yakar, S., LeRoith, D., & Brodt, P. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0001 · Cited by 1,017

Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors

Weiss, L. M. (1984) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198403000-00001 · Cited by 920 · cited 1×

Adrenocortical Carcinoma: Clinical Update

Allolio, B., & Fassnacht, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2639 · Cited by 775

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors

Mitsiades, C. S., Mitsiades, N., McMullan, C. J., Poulaki, V., Shringarpure, R., Akiyama, M., Hideshima, T., Chauhan, D., Joseph, M. G., Libermann, T. A., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00050-9 · Cited by 614

In vivo antitumor activity of NVP-AEW541—A novel, potent, and selective inhibitor of the IGF-IR kinase

Garcı́a-Echeverrı́a, C., Pearson, M. A., Marti, A., Meyer, T., Mestan, J., Zimmermann, J., Gao, J., Brueggen, J., Capraro, H., Cozens, R. M., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00051-0 · Cited by 543

An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma

Ribeiro, R. C., Sandrini, F., Figueiredo, B., Zambetti, G. P., Michalkiewicz, E., Lafferty, A. R., DeLacerda, L., Rabin, M., Cadwell, C., Sampaio, G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161479898 · Cited by 541

Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis.

Gazdar, A. F., Oie, H. K., Shackleton, C. H. L., Chen, T. R., Triche, T. J., Myers, C. E., Chrousos, G. P., Brennan, M. F., Stein, C. A., & Rocca, R. V. L. (1990) · PubMed · Cited by 446

Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients

Abiven, G., Coste, J., Groussin, L., Anract, P., Tissier, F., Legmann, P., Dousset, B., Bertagna, X., & Bertherat, J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2730 · Cited by 435

Chemotherapy for advanced adrenal cancer: improvement from a molecular approach?

Costa, R., Wesolowski, R., & Raghavan, D. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10464.x · Cited by 9

New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells

França, M. M., Lerário, A. M., Fragoso, M. C. B. V., & Lotfi, C. F. P. (2017) · Clinics · doi:10.6061/clinics/2017(06)10 · Cited by 9

Histopathological Criteria for Paediatric Adrenocortical Carcinoma

Paschoalin, V., Tucci, S., Estevanato, A. G., Tiraboschi, R. B., Antonini, S. R. R., Muglia, V. F., Chahud, F., Mermejo, L. M., de Bessa, J., & Molina, C. A. F. (2022) · Hormone Research in Paediatrics · doi:10.1159/000524892 · Cited by 9

Sensitivity of the Neuroendocrine Stress Axis in Metabolic Diseases

Cozma, D., Siatra, P., Bornstein, S. R., & Steenblock, C. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2201-6641 · Cited by 9

Gene-expression profiling of adrenocortical carcinoma

Suh, I., Guerrero, M. A., & Kebebew, E. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.13 · Cited by 9

Current issues in the diagnosis and management of adrenocortical carcinomas

Kassi, E. N., Kaltsas, G., Zografos, G., & Chrousos, G. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.6 · Cited by 9

GLUT1 expression in pediatric adrenocortical tumors: a promising candidate to predict clinical behavior

Pinheiro, C. M., Granja, S., Longatto‐Filho, A., Faria, A. M., Fragoso, M. C. B. V., Lovisolo, S. M., Bonatelli, M., Costa, R. F. A., Lerário, A. M., Almeida, M. Q., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19135 · Cited by 9

Targeting pediatric adrenocortical carcinoma: Molecular insights and emerging therapeutic strategies

Kuhlen, M., Schmutz, M., Kunstreich, M., Redlich, A., & Claus, R. (2025) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2025.102942 · Cited by 9

MicroRNA Era: The Importance for Diagnosis and Prognosis of Adrenocortical Tumors

Neto, J. E. B., & Latronico, A. C. (2014) · BioMed Research International · doi:10.1155/2014/381917 · Cited by 8

New Prognostic Indicators in Pediatric Adrenal Tumors

Jarzembowski, J. A. (2020) · Surgical pathology clinics · doi:10.1016/j.path.2020.08.002 · Cited by 9

Efficacy of oral metformin in a patient with metastatic adrenocortical carcinoma: Examination of mechanisms and therapeutic implications

Peixoto, R., Gomes, L. B. M., Sousa, T., Racy, D., Shigenaga, M. K., & Nagourney, R. (2018) · Rare Tumors · doi:10.1177/2036361317749645 · Cited by 8

Hsp90 inhibition in adrenocortical carcinoma: Limited drug synergism with mitotane

Sbiera, S., Kendl, S., Weigand, I., Sbiera, I., Faßnacht, M., & Kroiß, M. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.10.009 · Cited by 7

Roles of the Pathologist in Evaluating Surrogate Markers for Medical Therapy in Adrenocortical Carcinoma

Sasano, H., Satoh, F., & Nakamura, Y. (2014) · Endocrine Pathology · doi:10.1007/s12022-014-9334-7 · Cited by 7

The IGF2 methylation score for adrenocortical cancer: an ENSAT validation study

Creemers, S. G., Feelders, R. A., Valdés, N., Ronchi, C. L., Volante, M., van Hemel, B. M., Luconi, M., Ettaieb, M. H. T., Mannelli, M., Chiara, M., et al. (2020) · Endocrine Related Cancer · doi:10.1530/erc-19-0378 · Cited by 7

Expression profiles of the glucose-dependent insulinotropic peptide receptor and LHCGR in sporadic adrenocortical tumors

Costa, M. H. S., Latronico, A. C., Martin, R. M., Barbosa, A. S., Almeida, M. Q., Lotfi, C. F. P., Valassi, H. P. L., Nishi, M. Y., Lucón, A. M., Siqueira, S. A. C., et al. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0395 · Cited by 7

Relationship of obesity, body fat, benign adrenal tumors and the mediating mechanism: a two-step mendelian randomization study

Wang, Q., Lv, D., Wen, J., Zhou, H., Jia, M., Li, J., Du, H., & Shuang, W. (2025) · BMC Cancer · doi:10.1186/s12885-025-13774-0 · Cited by 6

Retrospective Analysis of Prognostic Factors in Pediatric Patients with Adrenocortical Tumor from Unique Tertiary Center with Long-Term Follow-Up

Bachega, F. S., Suartz, C. V., Almeida, M. Q., Balderrama-Brondani, V., Charchar, H. L. S., Lacombe, A. M. F., Martins-Filho, S. N., Soares, I. C., Zerbini, M. C. N., Dénes, F. T., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226641 · Cited by 6

Tumores adrenocorticais na criança: da abordagem clínica à avaliação molecular

Antonini, S. R. R., Colli, L. M., Ferro, L., Mermejo, L. M., & de Castro, M. (2011) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302011000800014 · Cited by 6

Medical management of adrenocortical carcinoma: Current recommendations, new therapeutic options and future perspectives

Amodru, V., Garcia, M.-E., Libé, R., Brue, T. C., Reznik, Y., & Castinetti, F. (2020) · Annales d Endocrinologie · doi:10.1016/j.ando.2020.12.003 · Cited by 6

Development and Characterization of 3-Dimensional Cell Culture Models of Adrenocortical Carcinoma

Feely, S., Mullen, N., Donlon, P. T., Reidy, E., Challapalli, R. S., Hassany, M., Sorushanova, A., Martínez, E. R., Owens, P., Quinn, A. M., et al. (2024) · Endocrinology · doi:10.1210/endocr/bqae159 · Cited by 6

Mitotane treatment in adrenocortical carcinoma: mechanisms of action and predictive markers of response to therapy

ALTIERI, B., Lalli, E., & Faggiano, A. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03601-0 · Cited by 5

N-type calcium channel v2.2 is a target of TCF21 in adrenocortical carcinomas

dos Santos, B., Kremer, J. L., Fragoso, M. C. B. V., & Lotfi, C. F. P. (2022) · Neoplasma · doi:10.4149/neo_2022_220106n25 · Cited by 4

A study of adrenocortical tumors in children and adolescents by a comparative genomic hybridization technique

Mateo, E. C. C., Lorea, C. F., Duarte, A. A., Moreno, D. A., Neder, L., Tucci, S., Scrideli, C. A., & Tone, L. G. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.02.006 · Cited by 6

Adrenocortical Carcinoma

Allolio, B., & Faßnacht, M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00106-4 · Cited by 5

Upregulation of TCF21 inhibits migration of adrenocortical carcinoma cells

Kremer, J. L., Auricino, T. B., Passaia, B. D. S., & Lotfi, C. F. P. (2021) · Discover Oncology · doi:10.1007/s12672-021-00417-6 · Cited by 4

Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas

Catalano, R., Nozza, E., Altieri, B., Esposito, E., Croci, G. A., Barbieri, A. M., Treppiedi, D., Bari, S. D., Kimpel, O., Detomas, M., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02115-0 · Cited by 4

Gene Expression and Regulation in Adrenocortical Tumorigenesis

Fonseca, A. L., Healy, J. M., Kunstman, J. W., Korah, R. M., & Carling, T. (2012) · Biology · doi:10.3390/biology2010026 · Cited by 4

5th International ACC Symposium: An Outlook to Current and Future Research on the Biology of Adrenocortical Carcinoma: Diagnostic and Therapeutic Applications

Lalli, E., & Sasano, H. (2015) · Hormones and Cancer · doi:10.1007/s12672-015-0240-3 · Cited by 4

Whole Transcriptome Profiling of Adrenocortical Tumors Using Formalin-Fixed Paraffin-Embedded Samples

Iwahashi, N., Umakoshi, H., Ogata, M., Fukumoto, T., Kaneko, H., Terada, E., Katsuhara, S., Uchida, N., Sasaki, K., Yokomoto‐Umakoshi, M., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.808331 · Cited by 4

The Role of Inositols in Endocrine and Neuroendocrine Tumors

Mormando, M., Puliani, G., Bianchini, M., Lauretta, R., & Appetecchia, M. (2024) · Biomolecules · doi:10.3390/biom14081004 · Cited by 3

High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study

Catalano, R., Altieri, B., Angelousi, A. G., Arosio, M., Bravi, F., Canu, L., Croci, G. A., Detomas, M., Esposito, E., Ferrante, E., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316573 · Cited by 3

Methods in Cellular and Molecular Pathology

Komminoth, P., Walch, A. K., Werner, M., & Perren, A. A. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1069-1_1 · Cited by 3

Long-Term Follow Up and Treatment Outcomes of A 2 Year-Old-Boy With Metastatic Testosterone-Secreting Adrenocortical Carcinoma

LoGiurato, D., Antal, Z., & Zhou, P. (2020) · AACE Clinical Case Reports · doi:10.4158/accr-2020-0354 · Cited by 2

The Insulin-Like Growth Factor System in Adrenocortical Growth Control and Carcinogenesis

Fottner, C., Niederle, I. M., & Weber, M. M. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_15 · Cited by 2

Adrenocortical Cancer in Children

Galindo, C. R., Zambetti, G. P., & Ribeiro, R. C. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_28 · Cited by 2

Actualités dans la tumorigenèse surrénalienne

Crand, A., Borson‐Chazot, F., & Brue, T. C. (2009) · Annales d Endocrinologie · doi:10.1016/s0003-4266(09)72472-2 · Cited by 1

Histopathological and Molecular Characteristics of Pediatric Adrenocortical Tumors: where Do we Stand?

Swart, C. C., & de Krijger, R. R. (2026) · Endocrine Pathology · doi:10.1007/s12022-026-09905-3 · Cited by 1

An organoid model of the human adrenal cortex identifies drivers of steroidogenesis and zonation

Akkerman, N., Xu, Q., Valdeolivas, A., Okuda, R., Gaspa-Toneu, L., Cubela, I., Richardson, M., Giroud, N., Camp, J. G., & Beumer, J. (2026) · Cell Press Blue · doi:10.1016/j.cpblue.2026.100015 · Cited by 1

Adrenocortical Tumors in Children

Galindo, C. R. (2022) · Pediatric oncology · doi:10.1007/978-3-030-92071-5_36 · Cited by 1

Age-related biological differences in children’s and adolescents’ very rare tumors

Virgone, C., Ami, T. B., Roganović, J., Bień, E., Réguerre, Y., Ferrari, A., Orbach, D. H., Godzinski, J. K., Bisogno, G., Farinha, N. J., et al. (2023) · EJC Paediatric Oncology · doi:10.1016/j.ejcped.2023.100027 · Cited by 1

Adrenocortical Cell Lines

Parmar, J., Kulharya, A. S., & Rainey, W. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_18 · Cited by 1

Estudo da Beta-catenina em tumores adrenocorticais humanos

Lima, L. D. O. (2014) · doi:10.11606/t.5.2014.tde-14082014-151107 · Cited by 1

Papel do LIN28, uma proteína ligadora de RNAs, na tumorigênese adrenocortical

Faria, A. M. (2014) · doi:10.11606/t.5.2014.tde-26022015-095301

Caracterização molecular e funcional de células de tumores adrenocorticais humanos.

Rodrigues, A. T. (2014) · doi:10.11606/d.42.2014.tde-13112014-160412

Análise da expressão e do silenciamento do receptor tipo 1 do fator de crescimento semelhante à insulina em tumores adrenocorticais humanos

Ribeiro, T. C. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2015.tde-16032015-161040

Análise do perfil de expressão de microRNAs em tumores adrenocorticais benignos e malignos humanos

Neto, J. E. B. (2014) · doi:10.11606/t.5.2014.tde-15082014-153113

Pathogenesis of Adrenocortical Tumors

Almeida, M. Q., Pinto, E. M., & Latronico, A. C. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-449-4_4

New Perspectives on Diagnostics, Prognosis, and Therapy in Aggressive Endocrine Tumours

Appetecchia, M., Wolffenbuttel, B. H. R., & AlJadir, S. J. (2012) · Journal of Oncology · doi:10.1155/2012/820938

Importância da via do mevalonato nas neoplasias do córtex adrenal

Valassi, H. P. L. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2011.tde-18022011-122810

Análise da viabilidade das células H295R, linhagem de carcinoma adrenocortical tumoral humano, tratadas com diferentes drogas antitumorais.

Silveira, E. R. (2014) · doi:10.11606/d.42.2014.tde-19022015-105918

Expressão do fator de crescimento similar à insulina 1 e 2 (IGF1 e IGF2) e receptor de IGF1 (IGF1R) no carcinoma papilífero da tireoide

Dias, E. O. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2014.tde-24022015-110719

Análise do número de cópias dos genes IGFIR, SF1 e FGFR4 em tumores adrenocorticais de crianças e adultos

Ribeiro, T. C. (2010) · doi:10.11606/d.5.2010.tde-20092010-173034

Genetics of Adrenal Tumors

Lerário, A. M., Giordano, T. J., & Hammer, G. D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00025-9

Local Control of Steroid Hormone Biosynthesis

Hofland, J. (2012) · EUR Research Repository (Erasmus University Rotterdam)

Análise dos genes DICER1 e TARBP2 em tumores do córtex da suprarrenal de crianças e adultos

de Sousa, G. R. V. (2015) · doi:10.11606/t.5.2015.tde-05102015-111010

Análise da expressão do fator de transcrição TCF21/POD-1 e de genes do ciclo celular em tumores adrenocorticais humanos.

Passaia, B. D. S. (2016) · doi:10.11606/d.42.2016.tde-05092016-150716

Genetics of Adrenocortical Cancers

Assié, G., & Bertherat, J. Y. (2016) · Springer eBooks · doi:10.1007/978-3-319-44136-8_4

Via Wnt/?-catenina em tumores adrenocorticais pediátricos

Leal, L. F. (2016) · doi:10.11606/d.17.2016.tde-06012016-181445

A expressão dos marcadores de células-tronco, SF1 e DAX1 no desenvolvimento do córtex adrenal humano e sua associação com a via Wnt/beta-catenina na tumorigênese adrenocortical

Cavalcanti, M. M. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2018.tde-24042018-164945

Adrenal Neoplasms

Phan, A. T., Habra, M. A., Grubbs, E. G., & Moran, C. A. (2012) · Wiley eBooks · doi:10.1002/9781118464557.ch10

Análise do perfil de expressão do miR-483-3p e do miR-630 em tumores adrenocorticais e o efeito dessa modulação na tumorigênese da adrenal

Corrêa, C. A. P. (2020) · doi:10.11606/t.17.2020.tde-05102020-102256

Role of the mTOR Pathway in Normal and Tumoral Adrenal Cells

Mc, E. (2010)

Análise dos genes ATRX e ZNRF3 como fatores de prognóstico do carcinoma adrenocortical

Balderrama-Brondani, V. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2021.tde-28092021-123423

ACTH-Independent Cushing’s Syndrome: Adrenocortical Tumors

Fragoso, M. C. B. V., Domenice, S., Latronico, A. C., & Mendonca, B. B. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-449-4_16

Contrasting Functions of Notch Signaling In Normal and Pathogenic Adrenal Biology.

Simon, D. P. (2012) · Deep Blue (University of Michigan)

Análise da regulação do fator de transcrição TCF21 e seu papel na migração e invasão celular em tumores.

Kremer, J. L. (2020) · doi:10.11606/t.42.2020.tde-04082021-160437

Avaliação do papel dos genes ATRX e DAXX na patogênese e no prognóstico de tumores adrenocorticais pediátricos

Stecchini, M. F. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2022.tde-06022023-112309

Genetics of adrenal tumors

Lerário, A. M., Mohan, D. R., Giordano, T. J., & Hammer, G. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00013-7

The Cytoskeleton in Adrenal Physiology and Tumours: Functional Roles and Emerging Molecular Targets

Catalano, R., Nozza, E., Esposito, E., Bari, S. D., Mantovani, G., & Peverelli, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110348

Rôle de la voie Wnt/ßcaténine dans la physiopathologie de la cortico-surrénale

Berthon, A. S. (2012) · theses.fr (ABES) · doi:10.70675/f153e745z2e77z4090zac69zb5d4866fd8bf

Progression tumorale dans un modèle murin de carcinogénèse surrénalienne ciblée induite par antigène T de SV 40 : Recherche de cibles thérapeutiques pour le corticosurrénalome.

Batisse‐Lignier, M. (2016) · theses.fr (ABES) · doi:10.70675/da93a26ez9c9fz48f8z99a6zb56d09dc5df6

Syndrome de Li-Fraumeni,Corticosurrénalomes et autres tumeurs pédiatriques

Renaux‐Petel, M. (2020) · theses.fr (ABES) · doi:10.70675/d4c4441az88bcz45bezbcafz2529a515c966

Patched as a new target for adrenocortical carcinoma treatment

Hasanovic, A. (2018) · theses.fr (ABES) · doi:10.70675/e4759414z32e1z4e77zbb6fz743df9c365d0

Diagnostic work-up in paediatric adrenocortical tumours: an international consensus

Antonini, S. R. R., Wiegering, V., Halah, M. P., Pinto, L. E. C., Atapattu, N., Md, P., Elias Jr., J., Eker, N., Faßnacht, M., Fragoso, M. C. B. V., et al. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag086

The dual IGF-1R/IR blocker, Linsitinib, modulates human orbital fibroblast activity and proliferation

Luffy, M., Wagner, S., Wolf, J., Ganz, A.-L., Michels, X., Zeidan, R., Kent, J. D., Douglas, R. S., & Kahaly, G. J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1920590

Rare Tumors of the Peripheral Nervous System

Brennan, B. M. D., Galindo, C. R., & Bisogno, G. (2011) · Pediatric oncology · doi:10.1007/978-3-642-04197-6_42

Expression of IGF-II, IGF-IR, SF-1 and DAX-1 genes in pediatric and adult adrenocortical tumors

Almeida, M. Q. D. (2008) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)

IGF2 and IGF1R in pediatric adrenocortical tumors: roles in metastasis and steroidogenesis

Lira, R. C. P., Fedatto, P. F., Antônio, D. S. M., Leal, L. F., Martinelli, C. E., de Castro, M., Tucci, S., Neder, L., Ramalho, L. N. Z., Seidinger, A. L., et al. (2016) · Endocrine Related Cancer · doi:10.1530/erc-15-0426 · Cited by 27

P01-27 Expression of IGF2 and IGF1R in pediatric adrenocortical tumors (ACT): Overexpression of IGF1R is associated with unfavorable event and metastasis in adrenocortical carcinomas

Lira, R. C. P., Fedatto, P. F., Martinelli, C. E., Antonini, S. R. R., Castro, M., Tucci, S. T., Neder, L., Ramalho, L. N. Z., Seidinger, A. L., Cardinalli, I., et al. (2012) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(12)60107-5 · Cited by 1

Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: high IGF-II expression in functional adrenocortical carcinomas

Ilvesmäki, V., Kahri, A. I., Miettinen, P. J., & Voutilainen, R. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.3.8370710 · Cited by 152

Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas

Catalano, R., Nozza, E., Altieri, B., Esposito, E., Croci, G. A., Barbieri, A. M., Treppiedi, D., Bari, S. D., Kimpel, O., Detomas, M., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02115-0 · Cited by 4